Novo Nordisk’s Wegovy won U.S. approval in June 2021 with a label that says it can be used for chronic weight management in patients with a body mass index (BMI) of 27 or more who have at least one weight-related ailment, or in any patient with a BMI of 30 or greater.
The U.S. Food and Drug Administration plans to hold an advisory panel meeting to discuss Perrigo Company Plc's over-the-counter (OTC) birth control pill in May, the drugmaker said on Tuesday.
The U.S. Food and Drug Administration (FDA) on Friday approved Pharming Group's drug to treat a rare genetic disorder that leads to a weakened immune system, the Dutch company said.